Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2025-12-31 @ 2:29 AM
Study NCT ID:
NCT03605069
Status:
TERMINATED
Last Update Posted:
2021-08-25
First Post:
2018-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene
Sponsor:
Phoenicis Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Recessive Dystrophic Epidermolysis Bullosa | View |
| None | EB | View |
| None | COL7A1 | View |
| None | RNA Therapies | View |
| None | Antisense oligonucleotide | View |
| None | Exon skipping | View |
| None | WINGS | View |
| None | Topical treatment | View |
| None | RDEB | View |
| None | Exon 73 | View |
| None | Mutations in exon 73 | View |
| None | Dominant Dystrophic Epidermolysis Bullosa | View |
| None | DDEB | View |